- Home
- UTHR vs TXRH Comparison
UTHR vs TXRH Comparison
Compare UTHR & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- TXRH
- Stock Information
- Founded
- UTHR 1996
- TXRH 1993
- Country
- UTHR United States
- TXRH United States
- Employees
- UTHR N/A
- TXRH N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- TXRH Restaurants
- Sector
- UTHR Health Care
- TXRH Consumer Discretionary
- Exchange
- UTHR Nasdaq
- TXRH Nasdaq
- Market Cap
- UTHR 15.9B
- TXRH 12.1B
- IPO Year
- UTHR 1999
- TXRH 2004
- Fundamental
- Price
- UTHR $372.81
- TXRH $182.30
- Analyst Decision
- UTHR Buy
- TXRH Buy
- Analyst Count
- UTHR 13
- TXRH 24
- Target Price
- UTHR $352.31
- TXRH $171.73
- AVG Volume (30 Days)
- UTHR 324.3K
- TXRH 620.2K
- Earning Date
- UTHR 10-30-2024
- TXRH 10-24-2024
- Dividend Yield
- UTHR N/A
- TXRH 1.34%
- EPS Growth
- UTHR 23.05
- TXRH 27.34
- EPS
- UTHR 21.73
- TXRH 5.51
- Revenue
- UTHR $2,616,700,000.00
- TXRH $4,948,532,000.00
- Revenue This Year
- UTHR $24.34
- TXRH $17.58
- Revenue Next Year
- UTHR $8.64
- TXRH $7.33
- P/E Ratio
- UTHR $17.21
- TXRH $33.09
- Revenue Growth
- UTHR 23.96
- TXRH 13.80
- 52 Week Low
- UTHR $208.62
- TXRH $93.79
- 52 Week High
- UTHR $377.02
- TXRH $184.17
- Technical
- Relative Strength Index (RSI)
- UTHR 68.21
- TXRH 63.98
- Support Level
- UTHR $349.40
- TXRH $173.35
- Resistance Level
- UTHR $357.24
- TXRH $177.55
- Average True Range (ATR)
- UTHR 7.66
- TXRH 3.33
- MACD
- UTHR 1.22
- TXRH 0.42
- Stochastic Oscillator
- UTHR 87.54
- TXRH 83.50
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company's operating segment includes Texas Roadhouse; Bubba's 33 and others. It generates maximum revenue from the Texas Roadhouse segment.